Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Sell
30
NNVC Quote, Financials, Valuation and Earnings
Last price:
$1.52
Seasonality move
:
37.26%
Day range:
$1.50 - $1.55
52-week range:
$1.00 - $3.59
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.17x
Volume:
719.6K
Avg. volume:
228.7K
1-year change:
41.67%
Market cap:
$22M
Revenue:
--
EPS (TTM):
-$0.76
Analysts' Opinion
-
Consensus RatingNanoviricides has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Nanoviricides has an estimated upside of 324.84% from its current price of $1.53.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $1.53.
Fair Value
-
According to the consensus of 0 analysts, Nanoviricides has 324.84% upside to fair value with a price target of -- per share.
NNVC vs. S&P 500
-
Over the past 5 trading days, Nanoviricides has overperformed the S&P 500 by 1.62% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Nanoviricides does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Nanoviricides has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Nanoviricides reported revenues of --.
Earnings Growth
-
Nanoviricides has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Nanoviricides reported earnings per share of -$0.23.
Enterprise value:
18.1M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-2.28x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -$7.1M | -$9.4M | -$9.7M | -$2M | -$3.2M | |
| EBITDA | -$6.3M | -$8.2M | -$8.7M | -$1.7M | -$2.9M | |
| Diluted EPS | -$0.62 | -$0.78 | -$0.76 | -$0.17 | -$0.23 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $22M | $19.9M | $13.1M | $7.1M | $4M | |
| Total Assets | $31.8M | $29.2M | $22.1M | $15.4M | $11.7M | |
| Current Liabilities | $1.9M | $869.5K | $518.4K | $948.3K | $1.6M | |
| Total Liabilities | $1.9M | $869.5K | $518.4K | $2.4M | $1.6M | |
| Total Equity | $30M | $28.3M | $21.6M | $13M | $10.1M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$6.2M | -$5.8M | -$7.7M | -$1.2M | -$2.6M | |
| Cash From Investing | -$344.5K | -$115.5K | -$195K | -$8.3K | -$46.8K | |
| Cash From Financing | -$234.3K | -$23.8K | $4.8M | -- | $1.7M | |
| Free Cash Flow | -$6.5M | -$5.9M | -$7.9M | -$1.2M | -$2.6M | |
NNVC
Sector
Market Cap
$22M
$43.9M
Price % of 52-Week High
42.62%
45.73%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
41.67%
-29.11%
Beta (5-Year)
0.886
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$1.49
200-day SMA
Sell
Level
$1.66
Bollinger Bands (100)
Sell
Level
1.35 - 1.79
Chaikin Money Flow
Sell
Level
-144.6M
20-day SMA
Buy
Level
$1.45
Relative Strength Index (RSI14)
Buy
Level
59.19
ADX Line
Sell
Level
15.55
Williams %R
Sell
Level
-19.0476
50-day SMA
Buy
Level
$1.43
MACD (12, 26)
Buy
Level
0.02
25-day Aroon Oscillator
Buy
Level
60
On Balance Volume
Neutral
Level
472M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (6)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
Stock Forecast FAQ
In the current month, NNVC has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NNVC average analyst price target in the past 3 months is --.
-
Where Will Nanoviricides Stock Be In 1 Year?
According to analysts, the consensus estimate is that Nanoviricides share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Nanoviricides?
Analysts are divided on their view about Nanoviricides share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Nanoviricides is a Sell and believe this share price will drop from its current level to --.
-
What Is Nanoviricides's Price Target?
The price target for Nanoviricides over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is NNVC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Nanoviricides is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of NNVC?
You can purchase shares of Nanoviricides via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Nanoviricides shares.
-
What Is The Nanoviricides Share Price Today?
Nanoviricides was last trading at $1.52 per share. This represents the most recent stock quote for Nanoviricides. Yesterday, Nanoviricides closed at $1.53 per share.
-
How To Buy Nanoviricides Stock Online?
In order to purchase Nanoviricides stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Sell
40
MSTR alert for Dec 24
MicroStrategy [MSTR] is down 8.7% over the past day.
Sell
26
NUTX alert for Dec 24
Nutex Health [NUTX] is up 9.77% over the past day.
Sell
48
VRNA alert for Dec 24
Verona Pharma PLC [VRNA] is up 7.96% over the past day.
